Skip to content

Determination of the optimal volume of remimazolam for anesthesia induction in elderly patients with hypertension:A Phase I/II Trial

Determination of the optimal volume of remimazolam for anesthesia induction in elderly patients with hypertension:A Phase I/II Trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115151
Enrollment
Unknown
Registered
2025-12-23
Start date
2025-12-23
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly patients with hypertension

Interventions

Intervention group:Anesthesia induction using remimazolam

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Elderly patients with hypertension (aged 65-80 years, gender not limited) who are scheduled to undergo non-cardiac surgery under general anesthesia should take their medication regularly. 2. American Society of Anesthesiologists (ASA) grade II - III; 3. Be capable of accepting rapid induction of general anesthesia with tracheal intubation; 4. Be aware of and agree to participate in the trial and sign a written informed consent form; 5. BMI 18-30 kg/m^2.

Exclusion criteria

Exclusion criteria: 1.history of cerebral or thoracic/abdominal aortic aneurysm; 2.allergy to any drugs administered in the study; 3.history of severe liver impairment,namely, ChildePugh class C; 4.currently undergoing maintenance dialysis; 5.congestive heart failure, namely, New York Heart Association classification III or IV, untreated or unstable ischaemic heart conditions;history of multiple premature ventricular contractions, multiple atrial premature contractions, or atrial fibrillation, severe sinus bradycardia (heart rate =180 mmHg and/or diastolic blood pressure >=110 mmHg; 9.unsuccessful initial intubation, presence or anticipation of airway management difficulties; 10.Frailty (with a FRAIL Scale score of 3-5).

Design outcomes

Primary

MeasureTime frame
Hypotension after general anesthesia induction;

Secondary

MeasureTime frame
maximum MAP after tracheal intubation;time from initiation of anaesthetic administration until LoC;number of administrations of vasopressor;

Countries

China

Contacts

Public ContactLijian Chen

The First Affiliated Hospital of Anhui Medical University

chenlijian77@126.com+86 139 6669 9467

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026